D

Degron Therapeutics

8 employees

Degron Therapeutics is a platform company in discovery of molecular glue degraders for cancer treatment.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Oncology
Inflammation
Metabolic
molecular glue degrader drugs

Date founded

2021

Funding rounds raised

Total raised

$22M

from 4 investors over 4 rounds

D

Degron Therapeutics raised $22M on June 9, 2022

Investors: Med-Fine Capital, 苏州凯风正德投资管理有限公司, 厦门德屹股权投资管理有限公司 and Baidu.ventures

FAQ